Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001258 · ClinicalTrials.gov registry record
Studies of Frontal Lobe Brain Functioning in Schizophrenia
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 1,039
- Enrollment target
NCT00001258 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 1,039 participants.
The verdict
NCT00001258 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 1,039 participants
- Enrollment target
Study Summary
The purpose of this study is to use brain imaging technology to investigate the role of the frontal lobe of the brain in the thinking of individuals with schizophrenia and other neuropsychiatric disorders and healthy volunteers. Participants in this study will undergo a positron emission tomography (PET) scan of the brain while performing neuropsychological tests. Some of the tests involve cognitive operations that depend upon the frontal cortex. Interactions between frontal lobe activation, cognitive behavior, and neuropharmacology will be assessed by measuring regional cerebral blood flow (rCBF) during treatment with drugs that may affect frontal lobe physiology....
Interventions
- DRUG Oxygen-15 Water
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,039 participants |
| Start Date | 1993-11-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001258
The ClinicalTrials.gov registry entry for NCT00001258 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,039 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oxygen-15 Water is the first listed.
NCT00001258 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001258 about?
NCT00001258 is a clinical study titled "Studies of Frontal Lobe Brain Functioning in Schizophrenia". The purpose of this study is to use brain imaging technology to investigate the role of the frontal lobe of the brain in the thinking of individuals with schizophrenia and other neuropsychiatric disorders and healthy volunteers. Participants in this study will undergo a positron emission tomography...
What is the current status of trial NCT00001258?
This trial is currently completed. The enrollment target is 1,039 participants. The study started on 1993-11-26.
What interventions are being tested in trial NCT00001258?
The interventions under investigation include: Oxygen-15 Water (DRUG).
Who is sponsoring clinical trial NCT00001258?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.